Background: Squamous carcinomas of the uterine cervix often carry mutations of the gene encoding for the catalytic sub-unit of kinase PI3K, . The locus of this gene at chromosome 3q26 and neighboring loci are also commonly amplified. The landscape of 3q26-amplified cases have not been previously characterized in detail in cervical cancer.
Methods: Published genomic data and associated clinical data from TCGA cervical cancer cohort were analyzed at cBioportal for amplifications in genes at 3q26. The clinical and molecular characteristics of the group of patients with 3q26 amplifications was compared with the group without 3q26 amplifications. Comparative prevalence of amplification and expression of genes at 3q26 in amplified squamous cervical cancer cases were surveyed as well as 3q26 amplifications in cervical cancer cell line databases.
Results: Amplification of 3q26 locus is a prevalent molecular lesion in cervical squamous cell carcinomas encountered in about 15% of cases in TCGA cohort of 247 patients. Cancer-related genes commonly amplified from 3q26 include , , , , , and TERC. Amplified cases do not completely overlap with mutant cases. Differences exist between 3q26-amplified and non-amplified carcinomas in the frequency of mutations and frequency of other amplifications. Most commonly over-expressed genes in 3q26 amplified cases include , , , and less commonly and .
Conclusion: The subset of squamous cervical carcinomas with 3q26 amplifications is not overlapping with cancers carrying mutations and contains, besides PIK3CA, other cancer-associated genes that are over-expressed at the mRNA level, including and . , a regulator of SCF ubiquitin ligase activity, may be a relevant pathogenic player given the importance of ubiquitination and the proteasome in the disease. These observations could form the basis for therapeutic exploitation in this subset of squamous cervical carcinomas.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395483 | PMC |
| http://dx.doi.org/10.3390/curroncol28040251 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Host Nuclear Genome Copy Number Variations Identify High-Risk Anal Precancers in People Living With HIV.
J Acquir Immune Defic Syndr
June 2024
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
Background: People living with HIV (PLWH) have substantially increased incidence of anal precancer and cancer. There are very little data regarding genomic disturbances in anal precancers among PLWH. In this study, specific chromosomal variants were identified in anal squamous intraepithelial lesions.
View Article and Find Full Text PDFPrevalence and Associations of Co-occurrence of Mutations and Chromosome 3q26 Amplification in Lung Cancer.
Glob Med Genet
June 2024
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
(nuclear factor erythroid-2-related factor-2) encodes a basic leucine zipper (bZIP) transcription factor and exhibits variations in various tumor types, including lung cancer. In this study, we comprehensively investigated the impact of simultaneous mutations on the survival of -mutant lung cancer patients within specific subgroups. A cohort of 1,103 lung cancer patients was analyzed using hybridization capture-based next-generation sequencing.
View Article and Find Full Text PDFCombined and Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading.
Int J Mol Sci
February 2024
Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.
The and genes map at 3q26, a chromosomal region frequently amplified in head and neck cancers, which is associated with poor prognosis. This study explores the clinical significance of and gene amplification in early tumorigenesis. Gene copy number was analyzed by real-time PCR in 62 laryngeal precancerous lesions and correlated with histopathological grading and laryngeal cancer risk.
View Article and Find Full Text PDFOncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis.
Front Immunol
August 2023
Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, United States.
Introduction: Amplification of human chromosome 3q26-29, which encodes oncoprotein ΔNp63 among other isoforms of the p63 family, is a feature common to squamous cell carcinomas (SCCs) of multiple tissue origins. Along with overexpression of ΔNp63, activation of the protooncogene, , whether by overexpression or oncogenic mutation, is frequently observed in many cancers. In this study, analysis of transcriptome data from The Cancer Genome Atlas (TCGA) demonstrated that expression of , particularly isoforms, and are significantly elevated in advanced squamous cell carcinomas of the head and neck (HNSCCs), suggesting pathological significance.
View Article and Find Full Text PDFBrief Report: Prognostic Relevance of 3q Amplification in Squamous Cell Carcinoma of the Lung.
JTO Clin Res Rep
April 2023
Department of Public Health Sciences, Henry Ford Health, Detroit, Michigan.
Introduction: Amplification of 3q is the most common genetic alteration identified in squamous cell carcinoma of the lung (LUSC), with the most frequent amplified region being 3q26 to 3q28.
Methods: In this analysis, we aim to describe the prognostic relevance of 3q amplification by focusing on a minimal common region (MCR) of amplification constituted of 25 genes. We analyzed 511 cases of LUSC from The Cancer Genome Atlas and included 476 in the final analysis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!